Topic guide
Articles and reference material connected to this topic, organised for clear reading.
Reading path
Aims/hypothesis Glucose-lowering therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors is associated with a low risk of hypoglycaemia. We hypothesise that DPP-4 inhibition prevents hypoglycaemia via increased…
Read guide →Use of dipeptidyl peptidase-4 inhibitors (DPP-4is) is associated with an increased risk for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes, according to study results publi…
Read guide →Use of dipeptidyl peptidase-4 inhibitors (DPP-4is) in people with type 2 diabetes mellitus (T2DM) who test positive for COVID-19 is independently associated with lower mortality in such patients, researchers r…
Read guide →Biguanides vs dipeptidyl peptidase-4 (DPP-4) inhibitors have a similar incidence of cardiac and cerebrovascular events, as well as disease-related complications, but are less costly to use in patients with typ…
Read guide →Gaba R, Mehta P, Balasubramanyam A. Evaluation and management of ketosis-prone diabetes. Expert Rev Endocrinol Metab . 2019 Jan. 14 (1):43-8. [QxMD MEDLINE Link] . Boike S, Mir M, Rauf I, et al. Ketosis-prone …
Read guide →Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care . 2003 Jan. 26 Suppl 1:S5-20. [QxMD MEDLINE Link] . Parker ED, Lin J, Mahoney T, et al. Economic Costs of …
Read guide →